Evidence map›Paper›PMID 32927725›Full record

ReviewInternational journal of molecular sciences2020

Obstacles against the Marketing of Curcumin as a Drug.

Kambiz Hassanzadeh, Lucia Buccarello, Jessica Dragotto, Asadollah Mohammadi, Massimo Corbo, Marco Feligioni

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Safety Evaluation of Spray-DriedJournal of pharmacopuncture · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Avian PathogenicVeterinary sciences · 2025
    Review
  8. Article
  9. Review
  10. The extract of zedoary-turmeric protects rats' kidneys from damage caused by cisplatin.Journal of advanced veterinary and animal research · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Kambiz HassanzadehEuropean Brain Research Institute (EBRI) Rita Levi Montalcini Foundation, Viale Regina Elena 295, 00161 Rome, Italy.ORCID 0000-0002-8737-312X
Lucia BuccarelloEuropean Brain Research Institute (EBRI) Rita Levi Montalcini Foundation, Viale Regina Elena 295, 00161 Rome, Italy.ORCID 0000-0002-3393-653X
Jessica DragottoEuropean Brain Research Institute (EBRI) Rita Levi Montalcini Foundation, Viale Regina Elena 295, 00161 Rome, Italy.
Asadollah MohammadiCellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj 66177-15175, Iran.
Massimo CorboDepartment of Neurorehabilitation Sciences, Casa Cura Policlinico, 20144 Milano, Italy.ORCID 0000-0003-0793-9830
Marco FeligioniEuropean Brain Research Institute (EBRI) Rita Levi Montalcini Foundation, Viale Regina Elena 295, 00161 Rome, Italy.
European Brain Research Institute · ITKurdistan University of Medical Sciences · IRUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the extensive public and scientific interest in the use of phytochemicals to prevent or treat human diseases in recent years, natural compounds have been highly investigated to elucidate their therapeutic effect on chronic human diseases including cancer, cardiovascular disease, and neurodegenerative disease. Curcumin, an active principle of the perennial herb

Indexed as

Anti-Inflammatory Agents, Non-SteroidalClinical Trials as TopicCurcumaCurcuminDrug DevelopmentHumansMarketingMolecular Targeted TherapyPhytotherapyAnti-Inflammatory Agents, Non-SteroidalCurcuminbioavailabilitycurcuminmarketingpharmacokinetic

Identifiers

PMID32927725
PMCPMC7554750
OpenAlexW3084122529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.